Literature DB >> 23993809

Lung cancer screening: past, present and future.

James H Finigan1, Jeffrey A Kern.   

Abstract

Lung cancer is the leading cause of cancer death for men and women. Most lung cancer cases are diagnosed at an advanced stage, when cure is no longer an option; this heavily influences mortality. Historically, attempts at lung cancer screening using chest x-rays and sputum cytology have failed to influence lung cancer mortality. However, the recent National Lung Screening Trial demonstrated that low-dose computed tomography screening for lung cancer decreases mortality. This article outlines the history of lung cancer screening, the current state of screening and possible future adjuncts to screening.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chest radiograph; Low-dose computed tomography; Lung cancer screening; National Lung Screening Trial

Mesh:

Year:  2013        PMID: 23993809      PMCID: PMC4102106          DOI: 10.1016/j.ccm.2013.03.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  30 in total

1.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.

Authors:  Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

2.  When the average applies to no one: personalized decision making about potential benefits of lung cancer screening.

Authors:  Peter B Bach; Michael K Gould
Journal:  Ann Intern Med       Date:  2012-10-16       Impact factor: 25.391

3.  Survival of patients with stage I lung cancer detected on CT screening.

Authors:  Claudia I Henschke; David F Yankelevitz; Daniel M Libby; Mark W Pasmantier; James P Smith; Olli S Miettinen
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

4.  Lung cancer detection. Results of a randomized prospective study in Czechoslovakia.

Authors:  A Kubík; J Polák
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

5.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

6.  Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.

Authors:  P M Marcus; E J Bergstralh; R M Fagerstrom; D E Williams; R Fontana; W F Taylor; P C Prorok
Journal:  J Natl Cancer Inst       Date:  2000-08-16       Impact factor: 13.506

7.  CT screening for lung cancer: five-year prospective experience.

Authors:  Stephen J Swensen; James R Jett; Thomas E Hartman; David E Midthun; Sumithra J Mandrekar; Shauna L Hillman; Anne-Marie Sykes; Gregory L Aughenbaugh; Aaron O Bungum; Katie L Allen
Journal:  Radiology       Date:  2005-02-04       Impact factor: 11.105

8.  Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography.

Authors:  M Kaneko; K Eguchi; H Ohmatsu; R Kakinuma; T Naruke; K Suemasu; N Moriyama
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

9.  Lung cancer screening: the Mayo program.

Authors:  R S Fontana; D R Sanderson; L B Woolner; W F Taylor; W E Miller; J R Muhm
Journal:  J Occup Med       Date:  1986-08

10.  Mass screening for lung cancer with mobile spiral computed tomography scanner.

Authors:  S Sone; S Takashima; F Li; Z Yang; T Honda; Y Maruyama; M Hasegawa; T Yamanda; K Kubo; K Hanamura; K Asakura
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

View more
  3 in total

Review 1.  Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer.

Authors:  Liangqing Ge; Ruizheng Shi
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Performance of an AI based CAD system in solid lung nodule detection on chest phantom radiographs compared to radiology residents and fellow radiologists.

Authors:  Alan A Peters; Amanda Decasper; Jaro Munz; Jeremias Klaus; Laura I Loebelenz; Maximilian Korbinian Michael Hoffner; Cynthia Hourscht; Johannes T Heverhagen; Andreas Christe; Lukas Ebner
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 3.005

3.  Cullin7 is required for lung cancer cell proliferation and is overexpressed in lung cancer.

Authors:  Xuelin Men; Lingcheng Wang; Wenfei Yu; Yuanrong Ju
Journal:  Oncol Res       Date:  2015       Impact factor: 5.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.